Search

Your search keyword '"Tom Mikkelsen"' showing total 450 results

Search Constraints

Start Over You searched for: Author "Tom Mikkelsen" Remove constraint Author: "Tom Mikkelsen"
450 results on '"Tom Mikkelsen"'

Search Results

1. Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond

2. Reporting on the establishment of a Privacy Preserving Record Linkage to Facilitate an Ongoing Crosswalk Between Research and Health Administrative Databases

3. Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas

4. Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.

5. FAIR in action: Brain-CODE - A neuroscience data sharing platform to accelerate brain research

6. Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma

7. Validating a novel deterministic privacy-preserving record linkage between administrative & clinical data: applications in stroke research

8. Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems

9. Using A Privacy Preserving Record Linkage to Facilitate an Ongoing Crosswalk Between Research and Health Administrative Databases

10. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

11. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

12. Big Data Needs Big Governance: Best Practices From Brain-CODE, the Ontario-Brain Institute’s Neuroinformatics Platform

13. Brain-CODE: A Secure Neuroinformatics Platform for Management, Federation, Sharing and Analysis of Multi-Dimensional Neuroscience Data

14. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

15. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

16. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

17. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

18. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

19. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

20. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

21. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

22. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

23. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

24. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

25. Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy

26. Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

27. The Corpus Callosum Wallerian Degeneration in the Unilateral Brain Tumors: Evaluation with Diffusion Tensor Imaging (DTI)

28. Insulin-like Growth Factor Binding Protein 7 Mediates Glioma Cell Growth and Migration

29. FK506 Binding Protein Mediates Glioma Cell Growth and Sensitivity to Rapamycin Treatment by Regulating NF-κB Signaling Pathway

30. Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation

31. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

32. Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates.

33. Cilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effects.

34. DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.

35. Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.

36. Data from Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas

37. Supplementary Data from Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas

39. Supplementary Figure 2 from A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma

40. Supplementary Table 1 from Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma

41. Data from A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma

42. Supplemental Figure from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

43. Supplemental Tables 1-3 from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

45. Data from Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma

46. Data from High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances

49. Supplementary Figure 2 from High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances

Catalog

Books, media, physical & digital resources